Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06685133 · ClinicalTrials.gov registry record
Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice
A clinical trial of Lung Cancer and Lung Nodule, sponsored by Noah Medical.
- Active
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT06685133: Active study of Lung Cancer and Lung Nodule, sponsored by Noah Medical.
NCT06685133 is a study of Lung Cancer and Lung Nodule that is active but no longer recruiting, run by Noah Medical. The registered enrollment target is 50 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06685133, a study of Lung Cancer and Lung Nodule, is active but no longer recruiting, sponsored by Noah Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.
Primary Outcome
Placing the scope in an adequate location which the physician operator judges as suitable to initiate biopsy.
Conditions Studied
Interventions
- DEVICE Robotic assisted bronchoscopy
Study Locations (2)
Tennessee
- CHI Memorial Hospital - Chattanooga
Virginia
- Inova Fairfax Medical Campus - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2027-10-30 |
What the registry record for NCT06685133 still lists
NCT06685133 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic assisted bronchoscopy is the first listed.
NCT06685133 reports a single indexed study location in Tennessee, Virginia.
Frequently Asked Questions
What is clinical trial NCT06685133 about?
NCT06685133 is a clinical study titled "Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice". A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.
What is the current status of trial NCT06685133?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2024-11-08. Estimated completion is 2027-10-30.
What conditions does trial NCT06685133 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Nodule.
What interventions are being tested in trial NCT06685133?
The interventions under investigation include: Robotic assisted bronchoscopy (DEVICE).
Who is sponsoring clinical trial NCT06685133?
This trial is sponsored by Noah Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06685133 being conducted?
This trial has 2 study locations across Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06685133's enrollment target sits among peer trials
50 264th of 409 higher than 141 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI